Intervention

Brexpiprazole, OPC-34712

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions5

Lead sponsors shown1

Clinical trials

2 shown

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeNCT01922258 · 2013-09-01

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationNCT01862640 · 2013-07-11

Common conditions

Agitation Associated With2 Alzheimer's Disease2 Alzheimer's Type2 Mental Disorder2 Nervous System Diseases2

Leading sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.2

Trial status mix

COMPLETED2

Phase mix

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.